Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels.
Morales-Santana S; García-Fontana B; García-Martín A; Rozas-Moreno P; García-Salcedo JA; Reyes-García R; Muñoz-Torres M; Diabetes Care, 2013, vol. 36, issue 6, p 1667, ISSN 19355548. ISBN 19355548.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef